Codexis Inc.

CDXS | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.38

+$0.02 (+1.47%)

At close: Sep 21, 2026, 4:00 PM ET

$1.40

+$0.02 (+1.45%)

Pre-market: Sep 22, 2026, 5:17 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+1.47%

(1D)

Rating

Updated: Aug 28, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $148.43M

1D Range

1.36 1.40

52W Range

0.96 2.98

Valuation (TTM)

PE -4.06

PB 4.50

EV/EBITDA -7.69

Valuation (NTM)

Forward PE N/A

Forward PEG 0.15

Price Target $8

Cash Flow

FCF Yield -8.2%

SBC Adj. FCF Yield -13.4%

SBC Impact -63.4%

Margins

Gross Margin 83.7%

Operating Margin -31.2%

FCF Margin -15.7%

Growth (CAGR)

Revenue 3Y | 5Y -7.8% | -1.3%

Dil EPS 3Y | 5Y 49.3% | -0.9%

FCF 3Y | 5Y 42.9% | -8.3%

Returns

ROA -25.6%

ROE -74.4%

ROIC -22.7%

Financial Health

Net Cash

$14.04M

Current Ratio 3.06

Interest Coverage -18.77

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Codexis, Inc. is a biotechnology firm dedicated to the discovery, development, and commercialization of enzymes and other protein-based solutions. Its diverse portfolio encompasses advanced biocatalys...

Sector Healthcare

Industry Biotechnology

Employees 146

IPO Date Apr 21, 2010

Website www.codexis.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 5, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

Upside

+479.71%

Buy (1)

Hold (0)

Sell (0)

Analyst Details ➞